Skip to main content

Peer Review reports

From: A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen

Original Submission
5 Oct 2016 Submitted Original manuscript
10 Oct 2016 Author responded Author comments - Emilie Lereclus
Resubmission - Version 2
10 Oct 2016 Submitted Manuscript version 2
28 Oct 2016 Reviewed Reviewer Report - Alan Lefor
17 Nov 2016 Reviewed Reviewer Report - Kjersti Flatmark
21 Dec 2016 Author responded Author comments - Emilie Lereclus
Resubmission - Version 3
21 Dec 2016 Submitted Manuscript version 3
9 Jan 2017 Reviewed Reviewer Report - Kjersti Flatmark
7 Feb 2017 Author responded Author comments - Emilie Lereclus
Resubmission - Version 4
7 Feb 2017 Submitted Manuscript version 4
5 Mar 2017 Reviewed Reviewer Report - Kjersti Flatmark
13 Mar 2017 Author responded Author comments - Emilie Lereclus
Resubmission - Version 5
13 Mar 2017 Submitted Manuscript version 5
Publishing
21 Mar 2017 Editorially accepted
27 Mar 2017 Article published 10.1186/s12885-017-3210-z

You can find further information about peer review here.

Back to article page